Business Description
Global Health Ltd
ISIN : INE474Q01031
Total Employee Number:
9,673Compare
Compare
Traded in other countries / regions
543654.India IPO Date
2022-11-16Description
Global Health Ltd provides healthcare services through private multi-speciality tertiary care hospitals in India's North and East regions, with key specialities in cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology. Its services include Second Opinion, Lab Tests & Diagnostics, Homecare, Buy Medicine, Telemedicine, and others. The Company also provides speciality care in Cardiac Care, Cancer Care, Neurosciences, Gastrosciences, and others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.93 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.3 | |||||
Debt-to-EBITDA | 1.12 | |||||
Interest Coverage | 7.96 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 13.92 | |||||
Beneish M-Score | -1.69 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.7 | |||||
3-Year EBITDA Growth Rate | 13.1 | |||||
3-Year EPS without NRI Growth Rate | 18.2 | |||||
3-Year Book Growth Rate | 17.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 23.96 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 16.93 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.31 | |||||
9-Day RSI | 46.66 | |||||
14-Day RSI | 51.1 | |||||
3-1 Month Momentum % | 9.77 | |||||
6-1 Month Momentum % | 18.62 | |||||
12-1 Month Momentum % | -1.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.67 | |||||
Quick Ratio | 2.54 | |||||
Cash Ratio | 1.76 | |||||
Days Inventory | 25.37 | |||||
Days Sales Outstanding | 27.75 | |||||
Days Payable | 79.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.04 | |||||
Dividend Payout Ratio | 0.02 | |||||
Forward Dividend Yield % | 0.04 | |||||
5-Year Yield-on-Cost % | 0.04 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -0.92 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 77.54 | |||||
Operating Margin % | 15.64 | |||||
Net Margin % | 11.88 | |||||
EBITDA Margin % | 22.6 | |||||
FCF Margin % | -5.64 | |||||
OCF Margin % | 15.25 | |||||
ROE % | 15.09 | |||||
ROA % | 10.38 | |||||
ROIC % | 13.92 | |||||
3-Year ROIIC % | 12.01 | |||||
ROC (Joel Greenblatt) % | 23.32 | |||||
ROCE % | 17.26 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 67.93 | |||||
Forward PE Ratio | 53.39 | |||||
PE Ratio without NRI | 65.98 | |||||
Price-to-Owner-Earnings | 63.35 | |||||
PEG Ratio | 2.21 | |||||
PS Ratio | 8.07 | |||||
PB Ratio | 9.53 | |||||
Price-to-Tangible-Book | 9.56 | |||||
Price-to-Operating-Cash-Flow | 52.96 | |||||
EV-to-EBIT | 46.61 | |||||
EV-to-EBITDA | 35.76 | |||||
EV-to-Revenue | 8.09 | |||||
EV-to-FCF | -143.33 | |||||
Price-to-GF-Value | 0.9 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.65 | |||||
Price-to-Graham-Number | 5.37 | |||||
Earnings Yield (Greenblatt) % | 2.14 | |||||
FCF Yield % | -0.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Global Health Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 46,833.67 | ||
| EPS (TTM) (₹) | 20.68 | ||
| Beta | 0.5083 | ||
| 3-Year Sharpe Ratio | 0.65 | ||
| 3-Year Sortino Ratio | 1.14 | ||
| Volatility % | 32.96 | ||
| 14-Day RSI | 51.1 | ||
| 14-Day ATR (₹) | 35.207214 | ||
| 20-Day SMA (₹) | 1424.81 | ||
| 12-1 Month Momentum % | -1.9 | ||
| 52-Week Range (₹) | 955.2 - 1490 | ||
| Shares Outstanding (Mil) | 268.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Global Health Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Global Health Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 0.500000 Cash Dividend | 2026-08-14 | 1,410.95 (+1.91%) | ||
| INR 0.500000 Cash Dividend | 2025-08-22 | 1,389.30 (-3.38%) |
Show
Entries
Global Health Ltd Frequently Asked Questions
What is Global Health Ltd(BOM:543654)'s stock price today?
The current price of BOM:543654 is ₹1404.70. The 52 week high of BOM:543654 is ₹1490.00 and 52 week low is ₹955.20.
When is next earnings date of Global Health Ltd(BOM:543654)?
The next earnings date of Global Health Ltd(BOM:543654) is .
Does Global Health Ltd(BOM:543654) pay dividends? If so, how much?
The Dividend Yield %  of Global Health Ltd(BOM:543654) is 0.04% (As of Today), Highest Dividend Payout Ratio of Global Health Ltd(BOM:543654) was 0.02. The lowest was 0.02. And the median was 0.02. The  Forward Dividend Yield % of Global Health Ltd(BOM:543654) is 0.04%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Global Health Ltd
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers